Central Trust Company’s Exponent EXPO Stock Holding History

Central Trust Company’s Portfolio EXPO Stock Details EXPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-27	Closed	-$1.76K	–	1609
2026 Q1	$1.76K	Buy	+27	New	+$1.92K	﹤0.01%	1376

Other funds holding EXPO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.36B AUM 17.81% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Central Trust Company's EXPO Position: Q2 2026 in Review

Central Trust Company sold out of Exponent (EXPO) in Q2 2026, closing a stake of 27 shares — an estimated $1.76K sold.

Central Trust Company first reported a position in EXPO in Q1 2026 and held it in 1 quarter. The position peaked at $1.76K in Q1 2026. 341 funds tracked by Wall St. Rank hold EXPO as of Q2 2026.

Central Trust Company reported no remaining Exponent position as of Q2 2026 after selling out during the quarter.
Central Trust Company sold 27 Exponent shares in Q2 2026, an estimated $1.76K.
Central Trust Company first reported a position in Exponent in Q1 2026 and held it in 1 quarter.
Central Trust Company's Exponent position peaked at $1.76K in Q1 2026.
341 funds tracked by Wall St. Rank held Exponent as of Q2 2026.

Based on Central Trust Company's 13F filing for Q2 2026, filed 31 Jul 2026.